{"retracted":false,"update":{"timestamp":1467849600000,"doi":"10.1038/srep28124","type":"correction"},"doi":"10.1038/srep26428","journal":"Scientific Reports","publisher":"Springer Nature","title":"Erratum: Erratum: Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice"}
